Oncocross financial statements
온코크로스KRX:382150 · KOSDAQ₩3,660-2.40%
2026-10-07 closeOncocross's published financial data is dated 2026-10-04. 2024 revenue was KRW 1.07B. 2024 operating profit was −KRW 6.97B.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy